Davide Noto
Overview
Explore the profile of Davide Noto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
110
Citations
1119
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mattina A, Giammanco A, Noto D, Geraci G, Nardi E, Barbagallo C, et al.
J Clin Med
. 2025 Feb;
14(4).
PMID: 40004776
Familial hypercholesterolemia (FH) is a genetic disorder characterized by high plasma levels of low-density lipoprotein cholesterol (LDL-C) and exposing patients to higher risk of early cardiovascular (CV) atherosclerotic diseases. Though...
2.
Noto D, Gagliardo C, Spina R, Giammanco A, Ciaccio M, Cefalu A, et al.
Mol Genet Genomics
. 2024 Dec;
300(1):4.
PMID: 39704901
This paper describes a novel methodology based on GWAS filtering, aimed to find novel phenotypes associated to genetic loci independently of canonical risk factors using the large database of UK...
3.
Giammanco A, Noto D, Nardi E, Gagliardo C, Scrimali C, Brucato F, et al.
Nutr Metab Cardiovasc Dis
. 2024 Sep;
35(2):103723.
PMID: 39271391
Background And Aims: Lipoprotein(a) [Lp(a)] is a well-recognized risk factor for atherosclerotic cardiovascular disease (ASCVD). Few data are available on the distribution of Lp(a) levels among subjects at different cardiovascular...
4.
Gagliardo C, Giammanco A, Vaglio A, Pegoraro F, Cefalu A, Averna M, et al.
Medicine (Baltimore)
. 2024 Apr;
103(17):e37870.
PMID: 38669404
Rationale: Erdheim-Chester disease (ECD) is a rare multisystemic disease characterized by the infiltration of multiple organs by foamy CD68 + CD1a-histiocytes. The genetic background consists of gain-of-function somatic mutations in...
5.
Gagliardo C, Noto D, Giammanco A, Catanzaro A, Cimino M, Lo Presti R, et al.
Eur J Clin Microbiol Infect Dis
. 2024 Apr;
43(6):1109-1118.
PMID: 38607579
Purpose: Acinetobacter baumannii (Ab) is a Gram-negative opportunistic bacterium responsible for nosocomial infections or colonizations. It is considered one of the most alarming pathogens due to its multi-drug resistance and...
6.
Scala I, Brodosi L, Rovelli V, Noto D, Burlina A
Mol Genet Metab Rep
. 2024 Mar;
39:101065.
PMID: 38425869
Objective: Phenylketonuria (PKU) is a metabolic disorder necessitating lifelong management to prevent severe neurological impairments. This paper synthesises clinical practices from Italian specialist centres to delineate a unified approach for...
7.
Chiesa G, Zenti M, Baragetti A, Barbagallo C, Borghi C, Colivicchi F, et al.
Nutr Metab Cardiovasc Dis
. 2023 Aug;
33(10):1866-1877.
PMID: 37586921
Aims: In view of the consolidating evidence on the causal role of Lp(a) in cardiovascular disease, the Italian Society for the Study of Atherosclerosis (SISA) has assembled a consensus on...
8.
Gagliardo C, Noto D, Giammanco A, Maltese S, Vecchio L, Lavatura G, et al.
Intern Emerg Med
. 2023 May;
18(4):1095-1107.
PMID: 37147490
Statin-induced autoimmune myositis (SIAM) represents a rare clinical entity that can be triggered by prolonged statin treatment. Its pathogenetic substrate consists of an autoimmune-mediated mechanism, evidenced by the detection of...
9.
Cefalu A, DErasmo L, Iannuzzo G, Noto D, Giammanco A, Montali A, et al.
Atherosclerosis
. 2022 Sep;
359:13-19.
PMID: 36152419
Background And Aims: Familial chylomicronaemia syndrome (FCS) is a rare autosomal recessive disorder, resulting in elevated triglycerides (TGs), abdominal pain and pancreatitis. Treatment options are limited. Lomitapide, a microsomal triglyceride...
10.
Gagliardo C, Noto D, Giammanco A, Savoja A, Panzica M, Lavatura G, et al.
Intern Emerg Med
. 2022 Jul;
17(8):2343-2347.
PMID: 35908014
No abstract available.